Why Consistency in Testing Matters
Every SAP has experienced it — you complete a thorough assessment, set clear education and treatment requirements, and then leave the testing step in the client’s hands. The result? Inconsistent test quality, mismatched cutoff levels, and gaps in reporting. One client might use a cheap rapid test at 100 ng/mL, another might find a lab that doesn’t align with DOT standards, and suddenly you’re left trying to interpret results that don’t provide the insight you need.
This inconsistency creates risk:
For the client
They may believe they’re “clean” from a weak non-DOT test, only to fail a DOT test later.
For the SAP
Testing is done at different standards that are chosen by the client.
For the employer
Confidence is shaken in the RTD process if the client fails the RTD test.
That’s why more SAPs are standardizing with PracticeDrugTest.com.
Our Service Ensures
Consistency
Every test uses a federally aligned non-DOT panel with the same cutoff levels as DOT, ensuring no weak links in the process.
Detailed reporting
If positive, results show the exact nanograms per milliliter (ng/mL), giving both you and your client precise insight into their levels.
Accountability
Every order produces a lab-based, chain-of-custody CCF, so you know the test was done correctly and is defensible if questioned.
Time savings
No more chasing clients about where or how they tested. You set the standard, and the client follows a clear, simple process.
DOT Confirmatory vs. Common Non-DOT Initial Screen Cutoffs (ng/mL)
When SAPs leave testing up to clients, they risk inconsistency. When SAPs direct clients to PracticeDrugTest.com, they gain confidence, uniformity, and the added benefit of documented levels that help guide future conversations. It’s not just about passing a test — it’s about protecting the integrity of the RTD process.